BSX
Price
$99.86
Change
-$2.85 (-2.77%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
147.98B
37 days until earnings call
ICCM
Price
$1.09
Change
+$0.10 (+10.10%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
74.14M
71 days until earnings call
Interact to see
Advertisement

BSX vs ICCM

Header iconBSX vs ICCM Comparison
Open Charts BSX vs ICCMBanner chart's image
Boston Scientific
Price$99.86
Change-$2.85 (-2.77%)
Volume$242.32K
Capitalization147.98B
IceCure Medical
Price$1.09
Change+$0.10 (+10.10%)
Volume$19.08K
Capitalization74.14M
BSX vs ICCM Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. ICCM commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and ICCM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (BSX: $102.71 vs. ICCM: $0.99)
Brand notoriety: BSX: Notable vs. ICCM: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 151% vs. ICCM: 29%
Market capitalization -- BSX: $152.19B vs. ICCM: $67.66M
BSX [@Medical/Nursing Services] is valued at $152.19B. ICCM’s [@Medical/Nursing Services] market capitalization is $67.66M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.75B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileICCM’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • ICCM’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than ICCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while ICCM’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • ICCM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ICCM.

Price Growth

BSX (@Medical/Nursing Services) experienced а -4.21% price change this week, while ICCM (@Medical/Nursing Services) price change was -4.32% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.30%. For the same industry, the average monthly price growth was +6.66%, and the average quarterly price growth was +7.44%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

ICCM is expected to report earnings on Nov 25, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($148B) has a higher market cap than ICCM($74.1M). BSX YTD gains are higher at: 14.991 vs. ICCM (-10.409). BSX has higher annual earnings (EBITDA): 4.65B vs. ICCM (-15.54M). BSX has more cash in the bank: 534M vs. ICCM (5.38M). ICCM has less debt than BSX: ICCM (2.37M) vs BSX (12B). BSX has higher revenues than ICCM: BSX (18.5B) vs ICCM (2.79M).
BSXICCMBSX / ICCM
Capitalization148B74.1M199,730%
EBITDA4.65B-15.54M-29,889%
Gain YTD14.991-10.409-144%
P/E Ratio59.45N/A-
Revenue18.5B2.79M663,796%
Total Cash534M5.38M9,920%
Total Debt12B2.37M506,329%
FUNDAMENTALS RATINGS
BSX vs ICCM: Fundamental Ratings
BSX
ICCM
OUTLOOK RATING
1..100
6492
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
5100
SMR RATING
1..100
64100
PRICE GROWTH RATING
1..100
3648
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
385

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICCM's Valuation (57) in the null industry is in the same range as BSX (82) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (5) in the Medical Specialties industry is significantly better than the same rating for ICCM (100) in the null industry. This means that BSX’s stock grew significantly faster than ICCM’s over the last 12 months.

BSX's SMR Rating (64) in the Medical Specialties industry is somewhat better than the same rating for ICCM (100) in the null industry. This means that BSX’s stock grew somewhat faster than ICCM’s over the last 12 months.

BSX's Price Growth Rating (36) in the Medical Specialties industry is in the same range as ICCM (48) in the null industry. This means that BSX’s stock grew similarly to ICCM’s over the last 12 months.

BSX's P/E Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for ICCM (100) in the null industry. This means that BSX’s stock grew somewhat faster than ICCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXICCM
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
44%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
62%
Bullish Trend 19 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPEU49.55-0.09
-0.18%
SPDR® Portfolio Europe ETF
BBJP66.75-0.43
-0.64%
JPMorgan BetaBuilders Japan ETF
SDG82.59-0.67
-0.80%
iShares MSCI Global Sust Dev Goals ETF
RSSL93.57-0.94
-0.99%
Global X Russell 2000 ETF
UYM25.38-0.53
-2.04%
ProShares Ultra Materials

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-1.56%
ISRG - BSX
71%
Closely correlated
-1.35%
SYK - BSX
67%
Closely correlated
-1.40%
MMSI - BSX
56%
Loosely correlated
-5.19%
ALC - BSX
49%
Loosely correlated
-1.74%
EW - BSX
49%
Loosely correlated
-0.56%
More

ICCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
-0.76%
SINT - ICCM
67%
Closely correlated
-4.19%
AMBFF - ICCM
45%
Loosely correlated
N/A
BSX - ICCM
32%
Poorly correlated
-1.56%
ILMN - ICCM
31%
Poorly correlated
-4.22%
PEN - ICCM
31%
Poorly correlated
-1.33%
More